Glioma antigen

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Because several antigenic peptides of human tumors that are recognized by T-lymphocytes have been identified, immune responses against cancer can now be artificially manipulated. Furthermore, since T-lymphocytes have been found to play an important role in the rejection of tumors by the host and also to have antigen-specific proliferative potentials and memory mechanisms, T-lymphocytes are thought to play a central role in cancer vaccination. Although multidisciplinary therapies have been attempted for the treatment of gliomas, the results remain unsatisfactory. For the development of new therapies against gliomas, it is required to identify tumor antigens as targets for specific immunotherapy. In this chapter, recent progress in research on glioma antigens is described.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Pages77-84
Number of pages8
Volume746
DOIs
Publication statusPublished - 2012

Publication series

NameAdvances in Experimental Medicine and Biology
Volume746
ISSN (Print)00652598

Fingerprint

T-cells
Glioma
Antigens
Tumors
T-Lymphocytes
Neoplasms
Neoplasm Antigens
Immunotherapy
Data storage equipment
Peptides
Vaccination
Therapeutics
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Toda, M. (2012). Glioma antigen. In Advances in Experimental Medicine and Biology (Vol. 746, pp. 77-84). (Advances in Experimental Medicine and Biology; Vol. 746). https://doi.org/10.1007/978-1-4614-3146-6_6

Glioma antigen. / Toda, Masahiro.

Advances in Experimental Medicine and Biology. Vol. 746 2012. p. 77-84 (Advances in Experimental Medicine and Biology; Vol. 746).

Research output: Chapter in Book/Report/Conference proceedingChapter

Toda, M 2012, Glioma antigen. in Advances in Experimental Medicine and Biology. vol. 746, Advances in Experimental Medicine and Biology, vol. 746, pp. 77-84. https://doi.org/10.1007/978-1-4614-3146-6_6
Toda M. Glioma antigen. In Advances in Experimental Medicine and Biology. Vol. 746. 2012. p. 77-84. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-3146-6_6
Toda, Masahiro. / Glioma antigen. Advances in Experimental Medicine and Biology. Vol. 746 2012. pp. 77-84 (Advances in Experimental Medicine and Biology).
@inbook{fcaeba81e7de46ad945360d1176ec573,
title = "Glioma antigen",
abstract = "Because several antigenic peptides of human tumors that are recognized by T-lymphocytes have been identified, immune responses against cancer can now be artificially manipulated. Furthermore, since T-lymphocytes have been found to play an important role in the rejection of tumors by the host and also to have antigen-specific proliferative potentials and memory mechanisms, T-lymphocytes are thought to play a central role in cancer vaccination. Although multidisciplinary therapies have been attempted for the treatment of gliomas, the results remain unsatisfactory. For the development of new therapies against gliomas, it is required to identify tumor antigens as targets for specific immunotherapy. In this chapter, recent progress in research on glioma antigens is described.",
author = "Masahiro Toda",
year = "2012",
doi = "10.1007/978-1-4614-3146-6_6",
language = "English",
isbn = "9781461431459",
volume = "746",
series = "Advances in Experimental Medicine and Biology",
pages = "77--84",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Glioma antigen

AU - Toda, Masahiro

PY - 2012

Y1 - 2012

N2 - Because several antigenic peptides of human tumors that are recognized by T-lymphocytes have been identified, immune responses against cancer can now be artificially manipulated. Furthermore, since T-lymphocytes have been found to play an important role in the rejection of tumors by the host and also to have antigen-specific proliferative potentials and memory mechanisms, T-lymphocytes are thought to play a central role in cancer vaccination. Although multidisciplinary therapies have been attempted for the treatment of gliomas, the results remain unsatisfactory. For the development of new therapies against gliomas, it is required to identify tumor antigens as targets for specific immunotherapy. In this chapter, recent progress in research on glioma antigens is described.

AB - Because several antigenic peptides of human tumors that are recognized by T-lymphocytes have been identified, immune responses against cancer can now be artificially manipulated. Furthermore, since T-lymphocytes have been found to play an important role in the rejection of tumors by the host and also to have antigen-specific proliferative potentials and memory mechanisms, T-lymphocytes are thought to play a central role in cancer vaccination. Although multidisciplinary therapies have been attempted for the treatment of gliomas, the results remain unsatisfactory. For the development of new therapies against gliomas, it is required to identify tumor antigens as targets for specific immunotherapy. In this chapter, recent progress in research on glioma antigens is described.

UR - http://www.scopus.com/inward/record.url?scp=84862995992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862995992&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3146-6_6

DO - 10.1007/978-1-4614-3146-6_6

M3 - Chapter

SN - 9781461431459

VL - 746

T3 - Advances in Experimental Medicine and Biology

SP - 77

EP - 84

BT - Advances in Experimental Medicine and Biology

ER -